Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Tumor cell membrane remodeling with universal ligand for CAR-T cells to inhibit solid tumors
Heterogeneity is a major obstacle to the success of CAR-T therapy in treating solid tumors. The complex tumor microenvironment and varying phenotypes of tumor cells might result in antigen escape, drug resista...